These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29064732)

  • 41. Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats.
    Seppen J; Bakker C; de Jong B; Kunne C; van den Oever K; Vandenberghe K; de Waart R; Twisk J; Bosma P
    Mol Ther; 2006 Jun; 13(6):1085-92. PubMed ID: 16581301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions.
    Ling C; Wang Y; Feng YL; Zhang YN; Li J; Hu XR; Wang LN; Zhong MF; Zhai XF; Zolotukhin I; Srivastava A; Ling CQ
    J Integr Med; 2015 Sep; 13(5):341-6. PubMed ID: 26343106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies.
    Kavita U; Dai Y; Salvador L; Miller W; Adam LP; Levesque PC; Zhang YJ; Ji QC; Pillutla RC
    Hum Gene Ther Methods; 2018 Dec; 29(6):237-250. PubMed ID: 30351228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adeno-associated virus-binding antibodies detected in cats living in the Northeastern United States lack neutralizing activity.
    Adachi K; Dissen GA; Lomniczi A; Xie Q; Ojeda SR; Nakai H
    Sci Rep; 2020 Jun; 10(1):10073. PubMed ID: 32572045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor.
    Pillay S; Zou W; Cheng F; Puschnik AS; Meyer NL; Ganaie SS; Deng X; Wosen JE; Davulcu O; Yan Z; Engelhardt JF; Brown KE; Chapman MS; Qiu J; Carette JE
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency.
    Tordo J; O'Leary C; Antunes ASLM; Palomar N; Aldrin-Kirk P; Basche M; Bennett A; D'Souza Z; Gleitz H; Godwin A; Holley RJ; Parker H; Liao AY; Rouse P; Youshani AS; Dridi L; Martins C; Levade T; Stacey KB; Davis DM; Dyer A; Clément N; Björklund T; Ali RR; Agbandje-McKenna M; Rahim AA; Pshezhetsky A; Waddington SN; Linden RM; Bigger BW; Henckaerts E
    Brain; 2018 Jul; 141(7):2014-2031. PubMed ID: 29788236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
    Fu H; DiRosario J; Kang L; Muenzer J; McCarty DM
    J Gene Med; 2010 Jul; 12(7):624-33. PubMed ID: 20603889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preexisting Neutralizing Antibodies against Different Adeno-Associated Virus Serotypes in Humans and Large Animal Models for Gene Therapy.
    Ail D; Dalkara D
    Adv Exp Med Biol; 2023; 1415():117-123. PubMed ID: 37440023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC.
    O'Leary C; Forte G; Mitchell NL; Youshani AS; Dyer A; Wellby MP; Russell KN; Murray SJ; Jolinon N; Jones SA; Stacey K; Davis DM; Henckaerts E; Palmer DN; Kamaly-Asl I; Bigger BW
    J Transl Med; 2023 Jul; 21(1):437. PubMed ID: 37407981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5
    Majowicz A; Salas D; Zabaleta N; Rodríguez-Garcia E; González-Aseguinolaza G; Petry H; Ferreira V
    Mol Ther; 2017 Aug; 25(8):1831-1842. PubMed ID: 28596114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy.
    Goedeker NL; Dharia SD; Griffin DA; Coy J; Truesdale T; Parikh R; Whitehouse K; Santra S; Asher DR; Zaidman CM
    Ther Adv Neurol Disord; 2023; 16():17562864221149781. PubMed ID: 36710722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.
    Fu H; Meadows AS; Ware T; Mohney RP; McCarty DM
    Mol Ther; 2017 Mar; 25(3):792-802. PubMed ID: 28143737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
    Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
    J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Single Surface-Exposed Amino Acid Determines Differential Neutralization of AAV1 and AAV6 by Human Alpha-Defensins.
    Porter JM; Oswald MS; Sharma A; Emmanuel S; Kansol A; Bennett A; McKenna R; Smith JG
    J Virol; 2023 Mar; 97(3):e0006023. PubMed ID: 36916912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).
    Erles K; Sebökovà P; Schlehofer JR
    J Med Virol; 1999 Nov; 59(3):406-11. PubMed ID: 10502275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assaying the Stability and Inactivation of AAV Serotype 1 Vectors.
    Howard DB; Harvey BK
    Hum Gene Ther Methods; 2017 Feb; 28(1):39-48. PubMed ID: 28192678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Broad functional correction of molecular impairments by systemic delivery of scAAVrh74-hSGSH gene delivery in MPS IIIA mice.
    Duncan FJ; Naughton BJ; Zaraspe K; Murrey DA; Meadows AS; Clark KR; Newsom DE; White P; Fu H; McCarty DM
    Mol Ther; 2015 Apr; 23(4):638-47. PubMed ID: 25592334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A convenient enzyme-linked immunosorbent assay for rapid screening of anti-adeno-associated virus neutralizing antibodies.
    Ito T; Yamamoto S; Hayashi T; Kodera M; Mizukami H; Ozawa K; Muramatsu S
    Ann Clin Biochem; 2009 Nov; 46(Pt 6):508-10. PubMed ID: 19729501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.